TRELAQWK 100

Description

TRELAQWK 100 is a once-weekly oral medication formulated for adults with type 2 diabetes mellitus (T2DM). It contains Trelagliptin 100 mg, a potent DPP-4 (Dipeptidyl Peptidase-4) inhibitor that supports blood glucose regulation. Designed for enhanced convenience and long-term adherence, this therapy works effectively alongside a healthy diet and regular physical activity. Active Ingredient: Trelagliptin 100 mg A long-acting DPP-4 inhibitor that boosts the effects of incretin hormones. These hormones help increase insulin secretion and decrease glucagon levels, thus improving blood sugar control. Key Advantages: Convenient once-weekly dosage enhances treatment adherence. Effectively reduces both fasting and post-meal blood glucose levels. Supports glycemic control without contributing to weight gain. Low likelihood of hypoglycemia when used alone or with non-insulin therapies. Suitable for monotherapy or combined use with other anti-diabetic agents like metformin or sulfonylureas. Mechanism of Action: TRELAQWK 100 works by blocking the DPP-4 enzyme, which breaks down incretin hormones such as GLP-1 and GIP. These hormones naturally increase insulin production after meals and reduce glucagon secretion, helping to lower blood sugar. Thanks to its extended half-life, Trelagliptin allows for effective once-weekly dosing, unlike other DPP-4 inhibitors that require daily intake. Dosage & Administration: Recommended Dose: One tablet per week or as advised by a healthcare provider. How to Take: May be taken with or without food—ideally on the same day each week. Missed Dose: Avoid doubling the dose; consult your doctor for guidance. Possible Side Effects: TRELAQWK 100 is generally well-tolerated, but some users may encounter: Headache Cold-like symptoms (nasopharyngitis) Constipation Upper respiratory tract infections Rare allergic skin reactions Seek medical attention immediately if you notice symptoms such as persistent abdominal discomfort, rashes, or signs of pancreatitis.